Funding Rounds
Pheon Therapeutics

Pheon Therapeutics Series A (2022, $68M)

Pheon Therapeutics

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $68.00M

Raised Date: 2022-01-01